Jiuzhou Pharma released its performance for the first half of the year, with a net profit attributable to the parent company of 526 million yuan, an increase of 10.70%

Jiuzhou Pharma released its semi-annual report for 2025, with operating revenue of 2.871 billion yuan, a year-on-year increase of 3.86%; net profit attributable to the parent company of 526 million yuan, a year-on-year increase of 10.70%; net profit excluding non-recurring gains and losses of 526 million yuan, a year-on-year increase of 12.40%. The basic earnings per share is 0.59 yuan, and it plans to distribute a cash dividend of 2.00 yuan (including tax) for every 10 shares to all shareholders